Transforming research to improve therapies for trauma in the twenty-first century.

Authors:
Juffermans NP; Gözden T; Brohi K; Davenport R; Acker JP and 4 more

Journal:
Crit Care

Publication Year: 2024

DOI:
10.1186/s13054-024-04805-6

PMCID:
PMC10865682

PMID:
38350971

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Crit Care

Abbreviation: Crit Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accuracy of respiratory muscle assessments to predict weaning outcomes: a systematic review and com…
Poddighe D; Van Hollebeke M; Choudhary YQ and 6 more (2024) - Transparency Score: 4/6
Administration of methylene blue in septic shock: pros and cons.
Arias-Ortiz J; Vincent JL. (2024) - Transparency Score: 3/6
Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterob…
Petit M; Bidar F; Fosse Q and 19 more (2024) - Transparency Score: 4/6
Coexistence of a fluid responsive state and venous congestion signals in critically ill patients: a…
Muñoz F; Born P; Bruna M and 15 more (2024) - Transparency Score: 3/6
Driving pressure of respiratory system and lung stress in mechanically ventilated patients with act…
Stamatopoulou V; Akoumianaki E; Vaporidi K and 3 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsPhilip C. Spinella: Consultant for Cerus, Hemanext, CSL Behring. Advisory board for Haima and Octapharma. Co-Founder and Chief Medical Office for Kalocyte. Nicole Juffermans: consultant for Octapharma. Advisory board for Bayer. Competing interests Philip C. Spinella: Consultant for Cerus, Hemanext, CSL Behring. Advisory board for Haima and Octapharma. Co-Founder and Chief Medical Office for Kalocyte. Nicole Juffermans: consultant for Octapharma. Advisory board for Bayer."

Evidence found in paper:

"Funding No funding applies to this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025